Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Matthew Christopher is active.

Publication


Featured researches published by Matthew Christopher.


Archive | 2015

Purine inhibitors of human phosphatidylinositol 3-kinase delta

Abdelghani Abe Achab; Michael D. Altman; Yongqi Deng; Solomon Kattar; Jason D. Katz; Joey L. Methot; Hua Zhou; Meredeth Mcgowan; Matthew Christopher; Yudith Garcia; Neville J. Anthony; Francesc Xavier Fradera Llinas; Liping Yang; Changwei Mu; Xiaona Wang; Feng Shi; Baijun Ye; Sixing Zhang; Xiaoli Zhao; Rong Zhang; Kin Chiu Fong; Xiansheng Leng


Archive | 2013

PYRAZOLYL DERIVATIVES AS SYK INHIBITORS

Michelle R. Machacek; Michael D. Altman; Eric Romeo; Dilrukshi Vitharana; Brandon Cash; Tony Siu; Hua Zhou; Matthew Christopher; Solomon Kattar; Andrew M. Haidle; Kaleen Konrad Childers; Matthew L. Maddess; Michael H. Reutershan; Yves Ducharme; David J. Guerin; Kerrie Spencer; Christian Beaulieu; Vouy Linh Truong; Daniel Guay; Alan B. Northrup; Brandon M. Taoka; Jongwon Lim; Christian Fischer; John W. Butcher; Ryan D. Otte; Binyuan Sun; John Michael Ellis


Archive | 2013

Substituted pyridine spleen tyrosine kinase (SYK) inhibitors

Andrew M. Haidle; Sandra Lee Knowles; Solomon Kattar; Denis Deschenes; Jason Burch; Joel Robichaud; Matthew Christopher; Michael D. Altman; James P. Jewell; Alan B. Northrup; Marc Blouin; John Michael Ellis; Hua Zhou; Christian Fischer; Adam J. Schell; Michael H. Reutershan; Brandon M. Taoka; Anthony Donofrio


Archive | 2012

Pyrrolopyrimidines as janus kinase inhibitors

Sean P. Ahearn; Matthew Christopher; Joon Jung; Qinglin Pu; Alexey Rivkin; Mark E. Scott; David J. Witter; Hyun Chong Woo; Brandon Cash; Christopher J. Dinsmore; David J. Guerin


Archive | 2013

SUBSTITUTED PHENYL SPLEEN TYROSINE KINASE (Syk) INHIBITORS

Andrew M. Haidle; Jason Burch; Daniel Guay; Jacques Yves Gauthier; Joel Robichaud; Jean Francois Fournier; John Michael Ellis; Matthew Christopher; Solomon Kattar; Graham F. Smith; Alan B. Northrup


Archive | 2013

Imidazolyl analogs as syk inhibitors

Jongwon Lim; Michael H. Reutershan; John Michael Ellis; Kaleen Konrad Childers; Anthony Donofrio; Michael D. Altman; Andrew M. Haidle; Anna A. Zabierek; Matthew Christopher; Jonathan Grimm; Jason Burch; Maria Emilia Di Francesco; Alessia Petrocchi; Christian Beaulieu; Vouy Linh Truong; Alan B. Northrup; Marc Blouin


Archive | 2013

SUBSTITUTED DIAZINE AND TRIAZINE SPLEEN TYROSINE KINEASE (SYK) INHIBITORS

Andrew M. Haidle; Michael D. Altman; Solomon Kattar; Matthew Christopher; John Michael Ellis; Christian Fischer; Alan B. Northrup; Kaleen Konrad Childers


Archive | 2009

Triazole derivatives for treatment of alzheimer's disease

Christian Fischer; Joey L. Methot; Hua Zhou; Adam J. Schell; Benito Munoz; Alexey Rivkin; Sean P. Ahearn; Stephanie M. Chichetti; Rachel N. Maccoss; Sam Kattar; Matthew Christopher; Chaomin Li; Andrew Rosenau; William Colby Brown


Archive | 2014

Substituted imidazopyridines as hdm2 inhibitors

Matthew Christopher; Francesc Xavier Fradera Llinas; Michelle R. Machacek; Michelle Martinez; Michael H. Reutershan; Manami Shizuka; Binyuan Sun; Christopher F. Thompson; B. Wesley Trotter; Matthew E. Voss; Michael D. Altman; Stephane Bogen; Ronald J. Doll


Archive | 2012

Cyanomethylpyrazole carboxamides as janus kinase inhibitors

Jason Brubaker; Matthew Lloyd Childers; Matthew Christopher; Joshua Close; Jason D. Katz; Joon Jung; Scott L. Peterson; Phieng Siliphaivanh; Tony Siu; Graham F. Smith; Luis Torres; Hyun Chong Woo; Jonathan R. Young; Hongjun Zhang

Collaboration


Dive into the Matthew Christopher's collaboration.

Researchain Logo
Decentralizing Knowledge